Skip to main content
Fig. 1 | Journal of Inflammation

Fig. 1

From: Tofacitinib reduces acute lung injury and improves survival in a rat model of sepsis by inhibiting the JAK-STAT/NF-κB pathway

Fig. 1

Results of survival analysis in 5 groups of rats. The experiment was divided into 5 groups: Sham group, CLP group, CLP + Tofa (1 mg/kg) group, CLP + Tofa (3 mg/kg) group, CLP + Tofa (10 mg/kg) group, After surgery, the rats were continuously observed for 7 days, and their status and survival were recorded, and the survival rates of each group were compared. (*P < 0.05 vs. CLP group, #P < 0.05 vs. Sham group)

Back to article page